New User? Sign Up | Sign In

Insider Trading - Allogene Therapeutics Inc. (ALLO)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
ALLO Insider Trading Transactions for Allogene Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-07-26
Sale
2019-07-30
6:23 pm
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
48,827 $29.44 $1,437,603 65,373
(Direct)
View
2019-09-16
Sale
2019-09-18
7:05 pm
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
48,827 $32.11 $1,567,666 66,067
(Direct)
View
2020-03-16
Sale
2020-03-18
4:31 pm
Allogene Therapeutics Inc. ALLO Chang David D
CEO
20,335 $19.31 $392,615 2,214,914
(Indirect
Direct)
View
2020-03-16
Sale
2020-03-18
4:32 pm
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
5,450 $19.73 $107,508 47,906
(Indirect
Direct)
View
2020-03-16
Sale
2020-03-18
4:32 pm
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
3,750 $19.19 $71,980 63,021
(Direct)
View
2020-06-04
Purchase
2020-06-04
4:04 pm
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
146,382 $47 $6,879,954 1,798,163
(Indirect
Direct)
View
2020-06-03
Sale
2020-06-05
5:43 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
489,220 $47.4 $23,188,152 20,727,086
(Indirect)
View
2020-06-15
Sale
2020-06-17
6:13 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
390,984 $42.18 $16,491,046 20,336,102
(Indirect)
View
2020-06-18
Sale
2020-06-22
6:25 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
314,792 $42.5 $13,379,623 20,021,310
(Indirect)
View
2020-06-23
Sale
2020-06-25
6:24 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
219,853 $44.04 $9,682,650 19,801,456
(Indirect)
View
2020-06-26
Sale
2020-06-30
4:53 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
85,151 $42.53 $3,621,601 19,716,306
(Indirect)
View
2020-08-03
Sale
2020-08-05
5:09 pm
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
31,553 $36.89 $1,164,121 353,902
(Direct)
View
2020-08-06
Sale
2020-08-10
4:34 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
37,445 $37.47 $1,403,031 18,716,306
(Indirect)
View
2020-09-01
Sale
2020-09-03
4:12 pm
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
25,000 $35.36 $883,966 353,902
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-07-18
Other
2019-07-22
4:26 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,186,078
(Indirect)
View
2019-07-18
Other
2019-07-22
4:26 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,186,078
(Direct)
View
2019-07-18
Other
2019-07-22
4:26 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,420,835
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
13,193 $2.27 65,373
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
23,815 $2.27 65,373
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
11,819 $2.27 65,373
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
13,193 $2.27 65,373
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
23,815 $2.27 65,373
(Direct)
View
2019-07-26
Exercise
2019-07-30
6:23 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
11,819 $2.27 65,373
(Direct)
View
2019-09-03
Option Award
2019-09-05
4:44 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Amado Rafael
EVP of R&D and CMO
105,162 $0 160,630
(Direct)
View
2019-09-03
Option Award
2019-09-05
4:44 pm
N/A
2029-09-02
Allogene Therapeutics Inc. ALLO Amado Rafael
EVP of R&D and CMO
160,630 $26.15 160,630
(Direct)
View
2019-09-05
Other
2019-09-09
6:02 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,429,052
(Direct)
View
2019-09-05
Other
2019-09-09
6:03 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,195,469
(Indirect)
View
2019-09-05
Other
2019-09-09
6:03 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,195,469
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
5,257 $2.27 66,067
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
22,503 $2.27 66,067
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
21,067 $2.27 66,067
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
5,257 $2.27 66,067
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
22,503 $2.27 66,067
(Direct)
View
2019-09-16
Exercise
2019-09-18
7:05 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
21,067 $2.27 66,067
(Direct)
View
2019-09-23
Other
2019-09-25
6:24 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,437,269
(Direct)
View
2019-09-23
Other
2019-09-25
6:27 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,205,963
(Indirect)
View
2019-09-23
Other
2019-09-25
6:27 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,205,963
(Direct)
View
2019-10-25
Other
2019-10-29
8:07 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,445,486
(Direct)
View
2019-10-25
Other
2019-10-29
8:08 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,215,354
(Indirect)
View
2019-10-25
Other
2019-10-29
8:08 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,215,354
(Direct)
View
2019-11-19
Other
2019-11-21
4:38 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,224,745
(Indirect)
View
2019-11-19
Other
2019-11-21
4:38 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,224,745
(Direct)
View
2019-11-19
Other
2019-11-21
4:43 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,007,080
(Direct)
View
2019-11-19
Gift
2019-11-21
4:43 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
446,623 $0 1,007,080
(Direct)
View
2020-02-20
Other
2020-02-24
5:14 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
237,155 $25.3 1,227,595
(Indirect)
View
2020-03-04
Other
2020-03-11
4:38 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,402 $0 2,234,136
(Indirect)
View
2020-03-04
Other
2020-03-11
4:38 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,391 $0 2,234,136
(Direct)
View
2020-03-04
Other
2020-03-11
4:39 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,217 $0 1,015,297
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:36 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
30,800 $0 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:36 pm
N/A
2030-03-17
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
109,600 $18.22 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Amado Rafael
EVP of R&D and CMO
30,800 $0 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
2030-03-17
Allogene Therapeutics Inc. ALLO Amado Rafael
EVP of R&D and CMO
109,600 $18.22 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
30,800 $0 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
2030-03-17
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
109,600 $18.22 109,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
2030-03-17
Allogene Therapeutics Inc. ALLO Chang David D
CEO
568,600 $18.22 568,600
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:38 pm
N/A
2030-03-17
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
379,066 $18.22 379,066
(Direct)
View
2020-04-24
Other
2020-04-28
4:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,198 $0 650,266
(Indirect)
View
2020-04-24
Other
2020-04-28
4:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
9,187 $0 650,266
(Direct)
View
2020-04-24
Gift
2020-04-28
4:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
428,022 $0 650,266
(Indirect)
View
2020-04-24
Gift
2020-04-28
4:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
428,022 $0 650,266
(Indirect)
View
2020-04-24
Other
2020-04-28
4:33 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
8,039 $0 1,023,336
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:03 pm
N/A
2030-06-05
Allogene Therapeutics Inc. ALLO MESSEMER DEBORAH M.
Director
16,640 $42.63 16,640
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:04 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
9,969 $0 1,033,305
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:05 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Humer Franz B
Director
9,969 $0 131,216
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:06 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
9,969 $0 246,151
(Direct)
View
2020-08-03
Exercise
2020-08-05
5:09 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
25,000 $2.27 353,902
(Direct)
View
2020-08-03
Exercise
2020-08-05
5:09 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
25,000 $2.27 353,902
(Direct)
View
2020-08-06
Other
2020-08-10
4:34 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
962,555 $0 18,716,306
(Indirect)
View
2020-08-13
Exercise
2020-08-14
4:04 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
32,451 $2.27 685,751
(Direct)
View
2020-08-13
Exercise
2020-08-14
4:04 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
32,451 $2.27 685,751
(Direct)
View
2020-09-01
Exercise
2020-09-03
4:12 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
25,000 $2.27 353,902
(Direct)
View
2020-09-01
Exercise
2020-09-03
4:12 pm
N/A
2028-06-25
Allogene Therapeutics Inc. ALLO Bhavnagri Veer
General Counsel
25,000 $2.27 353,902
(Direct)
View
Goto page 0, 1, Next